ArticleiScience2025

Phosphoproteomics profiling of sorafenib-resistant hepatocellular carcinoma patient-derived xenografts reveals potential therapeutic strategies.

Feng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.